LEIDEN, November 26, 2013 – BIOKÉ, a Cell Signaling Technology Europe (CST Europe) company, and RainDance Technologies, an innovative genomics tools company enabling ultra-sensitive detection of cancer and inherited diseases, announced an agreement allowing BIOKÉ to distribute RainDrop™ Digital PCR Systems in The Netherlands, Belgium, Luxembourg, and Germany, effective October 28, 2013.
“We are starting to see broad adoption of our new innovative RainDrop Digital PCR System across Europe and we look forward to working closely with the BIOKÉ team and sharing our knowledge to better serve our growing number of customers.”
Built on RainDance’s patented and proven RainStorm™ technology, the RainDrop Digital PCR System generates up to 10 million picoliter-sized droplets per lane. Since each droplet encapsulates a single molecule, researchers can quickly determine the absolute number of droplets containing specific target DNA and compare that to the number of droplets with background wild-type DNA. The RainDrop System also shifts the current digital PCR (dPCR) paradigm from a single-color-per-marker approach to a two color with varying probe intensity method that is capable of multiplexing up to 10 markers.
“When I first saw the RainDrop Digital PCR System, I was really impressed with the sensitivity, quantitation and multiplexing capabilities,” stated Koos Kranenborg, Director of Sales at BIOKÉ. “The RainDrop System fits perfectly within the innovative and pioneering product-portfolio of BIOKÉ. We are really looking forward to presenting this innovative droplet-based system to our customer base in the BeNeLux and Germany.”
“We selected BIOKÉ because of its years of experience working with cutting-edge genomics technologies and strong relationships with the key opinion leaders across the BeNeLux region and Germany,” said Sandy McBean, General Manager, Commercial Operations EMEA, RainDance Technologies. “We are starting to see broad adoption of our new innovative RainDrop Digital PCR System across Europe and we look forward to working closely with the BIOKÉ team and sharing our knowledge to better serve our growing number of customers.”
About RainDance Technologies
RainDance Technologies develops innovative products to enable research that will lead to more accurate, reliable, cost-effective and early detection of disease and risk predisposition in order to improve human healthcare. Today, RainDance is focused on better healthcare outcomes and lowering costs for the research, detection and treatment of cancers and inherited diseases. The company’s innovative RainStorm digital droplet technology powers next-generation sequencing and genetic testing systems that deliver dramatically superior performance, cost, interpretability, and ease of use. RainDance systems are used routinely in major academic research institutions, clinical genetics laboratories, and hospitals around the world. Based in Billerica, Massachusetts, the company supports customers through its international sales and service operations as well as a global network of distributors and commercial service providers.
BIOKÉ, founded in 2004, is a leading provider of Life Science and Diagnostics solutions in the Benelux. The young and dynamic company provides innovative, high-performance applications for genomics, proteomics, and molecular diagnostics. Since 2009, the office in Leiden is the European base of operations of Cell Signaling Technology.
With its technologies and equipment, BIOKÉ helps accelerate and improve diagnostics and research activities by enabling reproducible results. The company provides with customized solutions, including service support – not as a contractor, but as a knowledge partner. For additional information please visit the BIOKÉ website at www.bioke.com
The RainDrop Digital PCR System is for Research Use Only; not for use in diagnostic procedures.
RainDance Technologies, the RainDance Technologies logo, RainDrop, and RainStorm are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.